Abstract
Background/Objectives
Patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) often receive medical nutrition therapy (MNT) during intensive remission-induction treatment. Since little is known about changes in nutritional status, specifically body composition, in this patient population, these changes and their associations with physical and clinical outcomes were assessed.
Subjects/Methods
In this multicenter prospective observational study, newly diagnosed AML/MDS patients who received intensive remission-induction chemotherapy, routine dietary counseling by a dietician and MNT immediately upon inadequate nutritional intake, were included. At treatment initiation and discharge, nutritional status, including Patient-Generated Subjective Global Assessment (PG-SGA)-scores and body composition, physical outcomes and fatigue were assessed. Associations of nutritional status/body composition with physical outcomes, fatigue, fever duration, number of complications, time to neutrophil engraftment and hospital length of stay (LOS) (collected from medical records) were examined using multiple regression analysis.
Results
In >91% of the 126 AML/MDS patients included, nutritional intake was adequate, with 61% receiving MNT. Nevertheless, body weight decreased significantly (p < 0.001) and mainly consisted of a loss of muscle/fat-free mass (FFM) (p < 0.001), while fat mass (FM) remained unchanged (p-value range = 0.71–0.77). Body weight and waist circumference showed significant negative associations with fever duration and/or number of complications. Significant positive associations were found between mid-upper arm muscle circumference (MUAMC) and physical functioning and between PG-SGA-scores and fatigue. Body weight and MUAMC were also negatively associated with LOS.
Conclusion
Despite MNT in AML/MDS patients undergoing intensive chemotherapy, muscle/FFM decreased while FM remained unchanged. Maintenance of nutritional status was associated with improved physical and clinical outcomes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Data analyzed in this study are available from the corresponding author on reasonable request.
References
Comprehensive Cancer Center the Netherlands. The Netherlands Cancer Registry 2023. www.iknl.nl/nkr-cijfers. Accessed February 21, 2024.
Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200–28.
The Hemato Oncology Foundation for Adults in The Netherlands (HOVON), Leukemia Working Group. Treatment guideline AML (Dutch only). 2021. https://hovon.nl/en/treatment-guidelines/leukemia. Accessed February 21, 2024.
Walrath M, Bacon C, Foley S, Fung HC. Gastrointestinal side effects and adequacy of enteral intake in hematopoietic stem cell transplant patients. Nutr Clin Pr. 2015;30:305–10.
Baumgartner A, Bargetzi A, Zueger N, Bargetzi M, Medinger M, Bounoure L, et al. Revisiting nutritional support for allogeneic hematologic stem cell transplantation-a systematic review. Bone Marrow Transpl. 2017;52:506–13.
Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11–48.
Campelj DG, Timpani CA, Rybalka E. Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences. J Cachexia Sarcopenia Muscle. 2022;13:42–54.
Nakamura N, Ninomiya S, Matsumoto T, Nakamura H, Kitagawa J, Shiraki M, et al. Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia. Ann Hematol. 2019;98:351–9.
Ando T, Fujisawa S, Teshigawara H, Ogusa E, Ishii Y, Miyashita K, et al. Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia. Int J Hematol. 2019;109:673–83.
Jung J, Lee E, Shim H, Park JH, Eom HS, Lee H. Prediction of clinical outcomes through assessment of sarcopenia and adipopenia using computed tomography in adult patients with acute myeloid leukemia. Int J Hematol. 2021;114:44–52.
Brauer D, Backhaus D, Pointner R, Vucinic V, Niederwieser D, Platzbecker U, et al. Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation. Hemasphere. 2021;5:e532.
Baumgartner A, Zueger N, Bargetzi A, Medinger M, Passweg JR, Stanga Z, et al. Association of Nutritional Parameters with Clinical Outcomes in Patients with Acute Myeloid Leukemia Undergoing Haematopoietic Stem Cell Transplantation. Ann Nutr Metab. 2016;69:89–98.
Horsley P, Bauer J, Gallagher B. Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay. Bone Marrow Transpl. 2005;35:1113–6.
Morishita S, Kaida K, Tanaka T, Itani Y, Ikegame K, Okada M, et al. Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2012;20:3161–8.
Anderson LJ, Yin C, Burciaga R, Lee J, Crabtree S, Migula D, et al. Assessing Cachexia Acutely after Autologous Stem Cell Transplant. Cancers. 2019;11:1300.
Qin Z, Lu K, Jiang T, Wang M, Weng Y, Tang X, et al. Evaluating Sarcopenia by Using the Bioelectrical Impedance Analysis in Patients with Acute Myeloid Leukemia After Chemotherapy. Int J Gen Med. 2022;15:1261–9.
van Lieshout R, Tick LW, Dieleman JP, Custers S, van Dongen MS, van der Lee D, et al. Changes in body weight and serum liver tests associated with parenteral nutrition compared with no parenteral nutrition in patients with acute myeloid leukemia during remission induction treatment. Support Care Cancer. 2020;28:4381–93.
Deluche E, Girault S, Jesus P, Monzat S, Turlure P, Leobon S, et al. Assessment of the nutritional status of adult patients with acute myeloid leukemia during induction chemotherapy. Nutrition. 2017;41:120–5.
Iversen PO, Ukrainchenko E, Afanasyev B, Hulbekkmo K, Choukah A, Gulbrandsen N, et al. Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemia. Leuk Lymphoma. 2008;49:1916–24.
Eriksson KM, Cederholm T, Palmblad JE. Nutrition and acute leukemia in adults: relation between nutritional status and infectious complications during remission induction. Cancer. 1998;82:1071–7.
Cederholm T, Eriksson K, Palmblad J. Nutrition and acute leukemia in adults: relation to remission rate and survival. Haematol. 2002;32:405–17.
Esfahani A, Ghoreishi Z, Abedi Miran M, Sanaat Z, Ostadrahimi A, Eivazi Ziaei J, et al. Nutritional assessment of patients with acute leukemia during induction chemotherapy: association with hospital outcomes. Leuk Lymphoma. 2014;55:1743–50.
Cederholm T, Jensen GL, Correia M, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. Clin Nutr. 2019;38:1–9.
Baumgartner A, Schuetz P. Nutritional Support. In: Carreras E, Dufour C, Mohty M, Kroger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [https://www.ebmt.org/education/ebmt-handbook]. Cham (CH): Springer; 2019. Chapter 24, p. 171–6.
Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson Comorbidity Index: A Critical Review of Clinimetric Properties. Psychother Psychosom. 2022;91:8–35.
Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–47.
Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120:2454–65.
Pt-Global, Innovation in nutritional care. Patient-Generated Subjective Global Assessment (PG-SGA). Standard Operating Procedure and link to relevant literature on the PG-SGA, including: Jager-Wittenaar H, Ottery FD. Assessing nutritional status in cancer: role of the Patient-Generated Subjective Global Assessment. Curr Opin Clin Nutr Metab Care. 2017;20:322–9. https://pt-global.org/.
World Health Organisation BMI Categories. 2010. http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi. Accessed February 21, 2024.
Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gomez JM, et al. Bioelectrical impedance analysis-part I: review of principles and methods. Clin Nutr. 2004;23:1226–43.
Kyle UG, Genton L, Karsegard L, Slosman DO, Pichard C. Single prediction equation for bioelectrical impedance analysis in adults aged 20-94 years. Nutrition. 2001;17:248–53.
Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1981;34:2540–5.
Landi F, Russo A, Liperoti R, Pahor M, Tosato M, Capoluongo E, et al. Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Clin Nutr. 2010;29:441–7.
Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16:177–89.
Gonzalez MC, Mehrnezhad A, Razaviarab N, Barbosa-Silva TG, Heymsfield SB. Calf circumference: cutoff values from the NHANES 1999-2006. Am J Clin Nutr. 2021;113:1679–87.
Thompson E, Subar AF. Dietary Assessment Methodology. In: Coulston AM, Boushey CJ, Ferruzzi MG, Delahanty LM, editors. Nutrition in the Prevention and Treatment of Disease 4th ed. London: Elsevier Inc.; 2017. p. 5–44.
Kruizenga HM, Hofsteenge GH, Weijs PJ. Predicting resting energy expenditure in underweight, normal weight, overweight, and obese adult hospital patients. Nutr Metab. 2016;13:85.
Weijs PJ, Sauerwein HP, Kondrup J. Protein recommendations in the ICU: g protein/kg body weight - which body weight for underweight and obese patients? Clin Nutr. 2012;31:774–5.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.
Langius J, Visser W, Kruizenga H, Reijven N. Measuring protocol handgrip strength with Hand Dynanometer. Standard Operating Procedures, Nutritional Assessment Platform. Version 2. 2016. https://nutritionalassessment.nl/standard-operating-procedures-sops/. Accessed June 10, 2024.
Norman K, Stobaus N, Gonzalez MC, Schulzke JD, Pirlich M. Hand grip strength: outcome predictor and marker of nutritional status. Clin Nutr. 2011;30:135–42.
Dang A. Real-World Evidence: A Primer. Pharm Med. 2023;37:25–36.
National Cancer Institute, U.S. Department of Health and Human Services. Common Terminology Criteria of Adverse Events (CTCAE) version 5.0. 2017. http://ctep.cancer.gov, Accessed February 21, 2024.
Peseski AM, McClean M, Green SD, Beeler C, Konig H. Management of fever and neutropenia in the adult patient with acute myeloid leukemia. Expert Rev Anti Infect Ther. 2021;19:359–78.
Buffa R, Mereu E, Comandini O, Ibanez ME, Marini E. Bioelectrical impedance vector analysis (BIVA) for the assessment of two-compartment body composition. Eur J Clin Nutr. 2014;68:1234–40.
Malihi Z, Kandiah M, Chan YM, Hosseinzadeh M, Sohanaki Azad M, Zarif Yeganeh M. Nutritional status and quality of life in patients with acute leukaemia prior to and after induction chemotherapy in three hospitals in Tehran, Iran: a prospective study. J Hum Nutr Diet. 2013;26:123–31.
Brooks N, Cloutier GJ, Cadena SM, Layne JE, Nelsen CA, Freed AM, et al. Resistance training and timed essential amino acids protect against the loss of muscle mass and strength during 28 days of bed rest and energy deficit. J Appl Physiol. 2008;105:241–8.
Matsui R, Rifu K, Watanabe J, Inaki N, Fukunaga T. Impact of malnutrition as defined by the GLIM criteria on treatment outcomes in patients with cancer: A systematic review and meta-analysis. Clin Nutr. 2023;42:615–24.
Sucak GT, Suyani E, Baysal NA, Altindal S, Cakar MK, Aki SZ, et al. The role of body mass index and other body composition parameters in early post-transplant complications in patients undergoing allogeneic stem cell transplantation with busulfan-cyclophosphamide conditioning. Int J Hematol. 2012;95:95–101.
van Lieshout R, Lize N, Tick LW, van Deursen J, Driessen E, Janssen T, et al. Nutrition-related problems, nutritional support practices and barriers to adherence to nutritional guidelines during intensive treatment for acute myeloid leukemia: Patients’ and hematology nurses’ perspectives and experiences. Clin Nutr ESPEN. 2022;48:446–55.
Acknowledgements
We thank the Departments of Dietetics and Nutrition, the Departments of Physiotherapy and the Hematology Departments of the following hospitals for their participation in the current study: Albert Schweitzer Hospital, Dordrecht; Maxima MC, Veldhoven; Meander Medical Center, Amersfoort; and Sint Antonius Hospital, Nieuwegein. Furthermore, we thank Mara Lam, Aniek Schuurbiers, Mandy van Gils, Laura Boots, Dana Verhoeven and Eske Ruijters for their help in reviewing and entering the data.
Funding
This work was partially supported by the Vrienden Integrale Oncologische Zorg Foundation, Utrecht, The Netherlands (2017); Baxter B.V., Utrecht, The Netherlands (GHOL6759, 2018); Fresenius Kabi Nederland B.V., Huis ter Heide, The Netherlands (2019), Albert Schweitzer Hospital’s Research Fund, Dordrecht, The Netherlands (2019). These funding sources did not play any role in the design of the study, the collection, analysis and interpretation of data, in writing of the report nor in the decision to submit the article for publication.
Author information
Authors and Affiliations
Contributions
Rianne van Lieshout contributed to the conception of the study. Rianne van Lieshout and Sandra Beijer contributed to the design of the study. Rianne van Lieshout, Willemijn Biesbroek, Wanda Groenesteijn, Suzanne Kranenburg, Debbie van der Lee, Liesbeth van der Put, Nicky Rademakers, Claudia J. van Tilborg and Sandra de Zeeuw contributed to the acquisition of the data. Analysis of the data was performed by Rianne van Lieshout. Rianne van Lieshout, Lidwine W. Tick, Prof. Erik A.M. Beckers, Jeanne P. Dieleman, Harry R. Koene, Josien C. Regelink, Peter E. Westerweel, Em. Prof. Harry C. Schouten and Sandra Beijer contributed to the interpretation of the data. Rianne van Lieshout drafted the manuscript. All authors critically revised the manuscript for important intellectual content and approved the final version to be submitted.
Corresponding author
Ethics declarations
Competing interests
RvL has received unrestricted research grants from the Vrienden Integrale Oncologische Zorg Foundation, Utrecht, The Netherlands, Baxter B.V. Utrecht, The Netherlands (Grand reference number: GHOL6759) (Category 1), and Fresenius Kabi Nederland B.V., Huis ter Heide, The Netherlands (Category 1). C.J.v.T., S.d.Z. and P.E.W. have received an unrestricted research grant from the Albert Schweitzer Hospital’s Research Fund, Dordrecht, The Netherlands. The other authors have nothing to disclose.
Ethical approval
The study protocol was reviewed and exempted from ethics approval by the Medical Ethics Committee Maxima MC (N17025). The study procedures were in accordance with the rules of the European Personal Data Protection Act and the Code of Ethics of the World Medical Association (Helsinki Declaration). The study was registered at The Dutch Trial Register (NTR) with trial number NL8505. Written informed consent was obtained from all patients prior to enrollment in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
van Lieshout, R., Tick, L.W., Beckers, E.A.M. et al. Changes in nutritional status and associations with physical and clinical outcomes in acute myeloid leukemia patients during intensive chemotherapy. Eur J Clin Nutr (2024). https://doi.org/10.1038/s41430-024-01488-8
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41430-024-01488-8